AGP Executive Report
Last update: 2 hours agoEbola Response in Congo: WHO-backed researchers have started a clinical trial for Bundibugyo Ebola treatments in eastern Congo, testing a monoclonal antibody (MBP134) and an antiviral (remdesivir), as cases rise to 1,406 with 438 deaths. Rapid Testing Push: A separate race for a fast antigen test has narrowed to five manufacturers, aiming for field use in mid-July to speed isolation and containment. Wildlife Monitoring in Tchimpounga: New research confirms African manatees in the Tchimpounga Nature Reserve waterways, supported by local technician training and long-term acoustic monitoring. Water Science from the Congo River: A new study maps how Congo River fresh water spreads up to 800 km offshore, using modeling and observations to track mesoscale eddies that move it far from shore. Nature-Based Climate Financing: Africa’s leaders are urged to unlock nature-based solutions with stronger, innovative financing and environmental laws—so research turns into jobs and resilience. Tech & Finance in Congo: Optasia says its microfinancing platform is gaining traction, with growth expectations that include the Republic of Congo.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.